L.G. Pathberiya et al. / Tetrahedron 68 (2012) 9435e9439
9439
naphthalene-1-boronic acid (74 mg, 0.40 mmol) and potassium
carbonate (70 mg) in water (1 mL) and dioxane (5 mL) was satu-
rated with nitrogen. To this mixture was added tetrakis(-
triphenylphosphine)palladium (10 mg, 0.0087 mmol) and the
suspension refluxed under nitrogen for 15 h. The solvent was re-
moved in vacuo and a third of the residue was purified by reverse
phase prep HPLC (0e30 % acetonitrile in water over 30 min, 0.1%
TFA throughout) to provide the title compound as a white solid
Zn(NO3)2$6H2O (2 equiv). After 30 min, this stock solution was then
diluted to the required concentration with Tris buffer (10 mM, pH
7.5) and the solution utilised for fluorescence experiments.
4.3. Pyrophosphatase assay
To a solution of the complex (25
(10 mM, pH 7.5), MgCl2 (10 mM) was added PPi (4 equiv). After
5 min at 30 ꢂC, pyrophosphatase (7
M stock in 10 mM Tris buffer)
mM, 2-Zn2) in Tris buffer
(35 mg, 50%). 1H NMR (400 MHz, MeOD)
d
8.44 (d, J¼4.9 Hz, 4H,
m
pyridinyl H6), 7.88 (d, J¼8.1 Hz, 1H, naphthalenyl H8), 7.81 (d,
J¼8.1 Hz, 1H, naphthalenyl H2), 7.75 (d, J¼8.6 Hz, 1H, naphthalenyl
H5), 7.69 (t, J¼7.6 Hz, 4H, pyridinyl H4), 7.55 (d, J¼7.6 Hz, 4H, pyr-
idinyl H4), 7.50e7.42 (m, 3H, naphthalenyl H3, H6 and H7), 7.30 (d,
J¼7.4 Hz, 2H, naphthalenyl H4), 7.27e7.21 (m, 6H, pyridinyl H5 and
phenolic H3), 3.92 (s, 8H, NCH2Py), 3.88 (s, 4H, 2-methylphenol CH2).
was added to the solutions such that the final enzyme concentra-
tion was 120, 240, or 480 nM. The fluorescence spectrum was pe-
riodically measured to monitor consumption of PPi by the enzyme.
Acknowledgements
13C NMR (100 MHz, MeOD)
d 159.9, 156.5, 149.5, 138.6, 135.5, 133.1,
The authors acknowledge the support of the School of Chem-
istry and Department of Medicinal Chemistry, Monash University,
as well as Monash University for providing L.G.P. with a MIPRS and
MGS.
132.5, 132.4, 129.3, 128.2, 127.9, 127.0, 126.8, 126.7, 126.4, 125.0,
124.7, 124.7, 123.8, 60.8, 56.1. HPLC: 95% pure. LRMS (ESI): m/z:
643.2 (MþH, 55%). HRMS (ESI): m/z: calcd for [MþH]þ C42H39N6O:
643.3180, found: 643.3203.
4.1.4. 4-(Anthracen-9-yl)-2,6-bis((bis(pyridin-2-ylmethyl)amino)
methyl)phenol (3). A suspension of 2,6-bis((bis(pyridin-2-ylmethyl)
amino)methyl)-4-bromophenol (50 mg, 0.084 mmol), anthracene-
9-boronic acid (25 mg, 0.072 mmol) and potassium carbonate (2.0 g)
in water (10 mL) and dioxane (20 mL) was saturated with nitrogen.
To this mixture was added tetrakis(triphenylphosphine)palladium
(5 mg, 0.0043 mmol) and the suspension refluxed under nitrogen
for 15 h. The solution was acidified by dropwise addition of 2 M HCl
and washed with dichloromethane. The aqueous layer was then
freeze-dried and the residue purified by reverse phase prep HPLC
(0e30% acetonitrile in water over 30 min, 0.1% TFA throughout) to
provide the title compound as a white solid (40 mg, 69%). 1H NMR
References and notes
1. Gunnlaugsson, T.; Glynn, M.; Tocci, G. M.; Kruger, P. E.; Pfeffer, F. M. Coord. Chem.
Rev. 2006, 250, 3094e3117.
2. Sakamoto, T.; Ojida, A.; Hamachi, I. Chem. Commun. 2009, 141e152.
3. Kim, S. K.; Lee, D. H.; Hong, J.-I.; Yoon, J. Acc. Chem. Res. 2009, 42, 23e31.
ꢁ~
ꢁ
4. Martínez-Manez, R.; Sancenon, F. Chem. Rev. 2003, 103, 4419e4476.
5. Zhou, Y.; Xu, Z.; Yoon, J. Chem. Soc. Rev. 2011, 40, 2222e2235.
6. Hargrove, A. E.; Nieto, S.; Zhang, T.; Sessler, J. L.; Anslyn, E. V. Chem. Rev. 2011,
111, 6603e6782.
7. O’Neil, E. J.; Smith, B. D. Coord. Chem. Rev. 2006, 250, 3068e3080.
8. Ngo, H. T.; Liu, X.; Jolliffe, K. A. Chem. Soc. Rev. 2012, 41, 4928e4965.
€
9. Lipscomb, W. N.; Strater, N. Chem. Rev. 1996, 96, 2375e2434.
ꢁ
ꢁ
10. Ronaghi, M.; Karamohamed, S.; Pettersson, B.; Uhlen, M.; Nyren, P. Anal. Bio-
chem. 1996, 242, 84e89.
11. Roy, B.; Rao, A. S.; Ahn, K. H. Org. Biomol. Chem. 2011, 9, 7774e7779.
12. Zhang, J. F.; Kim, S.; Han, J. H.; Lee, S.-J.; Pradhan, T.; Cao, Q. Y.; Lee, S. J.; Kang,
C.; Kim, J. S. Org. Lett. 2011, 13, 5294e5297.
13. (a) Carolan, J. V.; Butler, S. J.; Jolliffe, K. A. J. Org. Chem. 2009, 74, 2992e2996; (b)
DiVittorio, K. M.; Johnson, J. R.; Johansson, E.; Reynolds, A. J.; Jolliffe, K. A.;
Smith, B. D. Org. Biomol. Chem. 2006, 4, 1966e1976; (c) Butler, S. J.; Jolliffe, K. A.
Org. Biomol. Chem. 2011, 9, 3471e3483.
14. Kim, H. J.; Lee, J. H.; Hong, J.-I. Tetrahedron Lett. 2011, 52, 4944e4946.
15. Lee, D. H.; Kim, S. Y.; Hong, J.-I. Angew. Chem., Int. Ed. 2004, 43, 4777e4780.
16. Ravikumar, I.; Ghosh, P. Inorg. Chem. 2011, 50, 4229e4231.
17. Lee, H. N.; Swamy, K. M. K.; Kim, S. K.; Kwon, J.-Y.; Kim, Y.; Kim, S.-J.; Yoon, Y. J.;
Yoon, J. Org. Lett. 2006, 9, 243e246.
18. Lee, H. N.; Xu, Z.; Kim, S. K.; Swamy, K. M. K.; Kim, Y.; Kim, S.-J.; Yoon, J. J. Am.
Chem. Soc. 2007, 129, 3828e3829.
19. Das, P.; Bhattacharya, S.; Mishra, S.; Das, A. Chem. Commun. 2011, 8118e8120.
20. Lee, D.-H.; Hong, J.-I. Bull. Korean Chem. Soc. 2008, 29, 497e498.
21. Lee, J. H.; Jeong, A. R.; Jung, J.-H.; Park, C.-M.; Hong, J.-I. J. Org. Chem. 2011, 76,
417e423.
(400 MHz, MeOD)
d
8.66 (d, J¼7.8 Hz, 4H, pyridinyl H6), 8.55 (s, 1H,
anthracenyl H10), 8.08 (d, J¼8.5 Hz, 2H, anthracenyl H4), 7.99 (d,
J¼7.8 Hz, 4H, pyridinyl H4), 7.59 (d, J¼7.8 Hz, 4H, pyridinyl H3), 7.54 (t,
J¼7.8 Hz, 4H, pyridinyl H5), 7.47 (t, J¼8.5 Hz, 2H, anthracenyl H3), 7.43
(d, J¼8.5 Hz, 2H, anthracenyl H1), 7.35 (s, J¼8.5 Hz, 2H anthracenyl
H2), 7.29 (s, 2H, phenolic H3), 4.48 (s, 8H, NCH2Py), 4.36 (s, 4H, 2-
methylphenol CH2). 13C NMR (100 MHz, MeOD)
d 157.1, 154.5, 148.4,
141.2, 136.3, 132.9, 131.6,131.3, 129.7, 128.0, 127.3, 126.7, 126.2, 125.7,
125.6, 122.1, 59.0, 57.0. HPLC: 95% pure. MS (ESI): m/z: 693.1 (MþH,
100%). HRMS (ESI): m/z: calcd for [MþH]þ C46H41N6O: 693.3336,
found: 693.3348.
4.2. Formation of zinc(II) complexes
22. Schwarz, F. P.; Wasik, S. P. Anal. Chem. 1976, 48, 524e528.
23. Weber, G.; Teale, F. W. J. Trans. Faraday Soc. 1957, 53, 646e655.
24. Kim, S. Y.; Hong, J.-I. Bull. Korean Chem. Soc. 2010, 31, 716e719.
To a solution of ligand 1, 2 or 3 (0.35 mg) in DMSO (40
added Tris buffer (1 mL, 10 mM, pH 7.5) and an aqueous solution of
mL) was